Biospecifics Technologies Corp (BSTC.OQ)
BSTC.OQ on NASDAQ Stock Exchange Global Market
43.83USD
19 Apr 2018
43.83USD
19 Apr 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$43.83
$43.83
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
8,388
8,388
52-wk High
$58.36
$58.36
52-wk Low
$38.12
$38.12
About
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)
Overall
| Beta: | 1.44 |
| Market Cap(Mil.): | $309.78 |
| Shares Outstanding(Mil.): | 7.19 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BSTC.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 25.33 | 200.91 | 33.50 |
| EPS (TTM): | 1.70 | -- | -- |
| ROI: | 18.34 | -0.75 | 13.17 |
| ROE: | 20.08 | -2.86 | 14.98 |
BRIEF-Biospecifics Technologies Q4 Earnings Per Share $0.36
* . REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BRIEF-Biospecifics Technologies reports Q3 eps of $0.37
* Biospecifics Technologies Corp reports Q3 2017 financial results
Competitors
| Price | Chg | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $127.55 | -0.17 |
| Novartis AG (NOVN.S) | CHF76.88 | -0.40 |
| Pfizer Inc. (PFE.N) | $36.53 | +0.04 |
| Roche Holding Ltd. (ROG.S) | CHF216.50 | 0.00 |
| Roche Holding Ltd. (RO.S) | CHF220.00 | -0.20 |
| Merck & Co., Inc. (MRK.N) | $58.64 | -0.28 |
| Bayer AG (BAYGn.DE) | €99.59 | -0.01 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €65.25 | -0.35 |
| GlaxoSmithKline plc (GSK.L) | 1,419.60 | +12.20 |
Estimates